Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • 5th Annual Pharma IPR...

    5th Annual Pharma IPR Conference to Focus on Global Patents Laws

    Written by savita thakur thakur Published On 2016-03-11T15:05:49+05:30  |  Updated On 11 March 2016 3:05 PM IST
    5th Annual Pharma IPR Conference to Focus on Global Patents Laws
    The 5th Annual Pharma IPR conference 2016, is on in Mumbai. The conference began on the 9th and will conclude today where leading experts from all over the world would be providing their distinctive perceptions on the Global Pharma Patent laws.

    Organized by UBM, a leading exhibition organizer, the focus of the conference is ­­to help people understand the intellectual property laws of the pharmaceutical industry of over 15 countries such as USA, Japan, Europe, Africa, India and Brazil.

    The conference will also have case studies on the line of Pharma and Bio-Pharma patents. There would be panel discussions by leading experts from US on IP strategies for Complex Generics followed by a question and answer session.

    Edward Pardon, a Partner at Merchant and Gould, one of US’s leading intellectual property firms spoke about the 101 patent ability decisions and their impact on treating the patents on a whole.

    One of the highlights of the conference was the moot court session where a simulated court experience discussing the pharma patent litigation case laws were enacted. The conference provides an opportunity for people to come together from different countries and debate about the latest patent cases that has been making headlines across the globe.

    Another highlight of the conference will be the panel discussion about Moving the Indian Pharma Industry to Innovations, where dignitaries from Panacea Biotec, MSF & Refry and Sagar would be its panel members.

    Distinguished industry speakers like Alpesh Pathak – Global IP Head, Intas Pharmaceuticals Ltd. Leena Menghaney – Regional Head – South Asia, MSF – Access Campaign; Taranpreet Singh Lamba, Vice President – Intellectual Property Management, Glenmark Pharmaceuticals; Mandar Kodgule – Senior Vice President, Global IP & Corporate Strategy, Wockhardt Ltd.; Aaron F Barkoff – Shareholder, Mcandrews; Mahalaxmi Andheria – Vice President – Intellectual Property Cell, Panacea Biotec Ltd.; Dennies Varughese, Pharm.D. Director, Sterne Kessler Goldstein & Fox; Jonathan Atkinson – Partner, HGF; Paul A Braier, Ph.D. Esq – Partner, Greenblum & Bernstein, P.L.C., USA are some of the distinguished people who would be gracing the conference with their presence.

    5th Annual PharmaAaron F BarkoffEdward PardonGlenmark PharmaceuticalsGlobal Pharma Patent lawsindian pharma industryIntas Pharmaceuticals Ltd.IPRLeena MenghaneyPaul A BraierTaranpreet Singh Lamba
    Source : The Dollar Business

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok